In our work, we aimed to investigate the mechanism of artesunate-induced growth inhibition in lung adenocarcinoma cells of human, which reported that the anticancer effects of artesunate is related to its ability in downregulating AKT/Survivin signaling in A549 cells. This evidence concerns the gene AKT1 and lung adenocarcinoma.